These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 18826367)

  • 1. Hypophysectomy for prostate cancer: a revival of old knowledge?
    Flitsch J; Bernreuther C; Hagel C; Lüdecke DK
    J Neurosurg; 2008 Oct; 109(4):760-4. PubMed ID: 18826367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypophysectomy in the treatment of disseminated carcinoma of the breast and prostate gland.
    Tindall GT; Ambrose SS; Christy JH; Patton JM
    South Med J; 1976 May; 69(5):579-83. PubMed ID: 1273614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Outcome of somatostatin analogue treatment in acromegaly].
    Mondok A; Tóth M; Patócs A; Szücs N; Igaz P; Pusztai P; Czirják S; Beko G; Gláz E; Rácz K; Tulassay Z
    Orv Hetil; 2009 Aug; 150(31):1457-62. PubMed ID: 19617182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determining optimal MRI follow-up after transsphenoidal surgery for pituitary adenoma: scan at 24 hours postsurgery provides reliable information.
    Kiliç T; Ekinci G; Seker A; Elmaci I; Erzen C; Pamir MN
    Acta Neurochir (Wien); 2001 Nov; 143(11):1103-26. PubMed ID: 11731862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Extradural temporopolar approach for giant pituitary adenomas invading the cavernous sinus and parasellar regions].
    Tamiya T; Ono Y; Date I; Kawauchi M; Matsumoto K; Ohmoto T
    No Shinkei Geka; 1998 Sep; 26(9):803-11. PubMed ID: 9757457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is insulin growth factor-1 (IGF-1) playing a role for aneurysm formation in patients with pituitary gland tumor?
    Kulseng B; Myhre HO
    Int Angiol; 2006 Dec; 25(4):433-5. PubMed ID: 17164753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor-1 is associated with regulation of the luteinizing hormone production in men receiving androgen deprivation therapy with gonadotropin-releasing hormone analogues for localized prostate cancer.
    Hara N; Takizawa I; Isahaya E; Nishiyama T; Hoshii T; Ishizaki F; Takahashi K
    Urol Oncol; 2012 Sep; 30(5):596-601. PubMed ID: 21458314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octreotide as primary therapy for acromegaly.
    Newman CB; Melmed S; George A; Torigian D; Duhaney M; Snyder P; Young W; Klibanski A; Molitch ME; Gagel R; Sheeler L; Cook D; Malarkey W; Jackson I; Vance ML; Barkan A; Frohman L; Kleinberg DL
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3034-40. PubMed ID: 9745397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary metastasis of prostate cancer presenting as a unilateral third nerve palsy.
    Ahmad S; Smeeton F; Hayhurst C; Lansdown A
    BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32532912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of acromegaly in a diabetic cat with transsphenoidal hypophysectomy.
    Meij BP; Auriemma E; Grinwis G; Buijtels JJ; Kooistra HS
    J Feline Med Surg; 2010 May; 12(5):406-10. PubMed ID: 20417901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year follow-up of a 13-year-old boy with a pituitary adenoma causing gigantism--effect of octreotide therapy.
    Schoof E; Dörr HG; Kiess W; Lüdecke DK; Freitag E; Zindel V; Rascher W; Dötsch J
    Horm Res; 2004; 61(4):184-9. PubMed ID: 14739526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic radiosurgery for metastatic tumors in the pituitary gland and the cavernous sinus.
    Mori Y; Kobayashi T; Shibamoto Y
    J Neurosurg; 2006 Dec; 105 Suppl():37-42. PubMed ID: 18503328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in localized, metastasized prostate cancer and benign prostatic hyperplasia.
    Aksoy Y; Aksoy H; Bakan E; Atmaca AF; Akçay F
    Urol Int; 2004; 72(1):62-5. PubMed ID: 14730168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary magnetic resonance imaging findings do not influence surgical outcome in adrenocorticotropin-secreting microadenomas.
    Salenave S; Gatta B; Pecheur S; San-Galli F; Visot A; Lasjaunias P; Roger P; Berge J; Young J; Tabarin A; Chanson P
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3371-6. PubMed ID: 15240617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of a hemorrhagic non-functioning pituitary adenoma presenting with abducens nerve palsy].
    Tanioka D; Abe T; Kunii N; Izumiyama H
    No Shinkei Geka; 2005 May; 33(5):473-9. PubMed ID: 15912767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
    Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
    Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case].
    Deme D; Ragán M; Kalmár K; Kovács L; Varga E; Varga T; Rakonczai E
    Magy Onkol; 2010 Dec; 54(4):351-7. PubMed ID: 21163766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging as a predictor of response to somatostatin analogs in acromegaly after surgical failure.
    Puig-Domingo M; Resmini E; Gomez-Anson B; Nicolau J; Mora M; Palomera E; Martí C; Halperin I; Webb SM
    J Clin Endocrinol Metab; 2010 Nov; 95(11):4973-8. PubMed ID: 20739382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of somatostatin analog, dexamethasone, and standard androgen ablation therapy in stage D3 prostate cancer patients with bone metastases.
    Koutsilieris M; Mitsiades CS; Bogdanos J; Dimopoulos T; Karamanolakis D; Milathianakis C; Tsintavis A
    Clin Cancer Res; 2004 Jul; 10(13):4398-405. PubMed ID: 15240528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.